Liên Minh Châu Âu - Tiếng Estonia - EMA (European Medicines Agency)

intervacc ab - recombinant streptococcus equi protein cce, recombinant streptococcus equi protein eq85, recombinant streptococcus equi protein idee - hobuslaste immunoloogilised vahendid - hobused - for the active immunisation to reduce clinical signs and the number of abscesses in acute stage of infection with s. equi.

Liên Minh Châu Âu - Tiếng Estonia - EMA (European Medicines Agency)

laboratorios lesvi s.l. - dimetüülfumaraat - sclerosis multiplex, relapsing-remitting - immunosupressandid - dimethyl fumarate neuraxpharma is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.

Liên Minh Châu Âu - Tiếng Estonia - EMA (European Medicines Agency)

bristol-myers squibb pharma eeig - cd19-directed genetically modified autologous cell-based product consisting of purified cd8+ t-cells (cd8+ cells), cd19-directed genetically modified autologous cell-based product consisting of purified cd4+ t cells (cd4+ cells) - lymphoma, large b-cell, diffuse; lymphoma, follicular; mediastinal neoplasms - antineoplastilised ained - breyanzi is indicated for the treatment of adult patients with diffuse large b-cell lymphoma (dlbcl), high grade b-cell lymphoma (hgbcl), primary mediastinal large b-cell lymphoma (pmbcl) and follicular lymphoma grade 3b (fl3b), who relapsed within 12 months from completion of, or are refractory to, first-line chemoimmunotherapy.

Liên Minh Châu Âu - Tiếng Estonia - EMA (European Medicines Agency)

sandoz gmbh - trastuzumab - breast neoplasms; stomach neoplasms - antineoplastilised ained - treatment of metastatic and early breast cancer and metastatic gastric cancer (mgc).

Estonia - Tiếng Estonia - Ravimiamet

tillotts pharma ab - makrogool+naatriumkloriid+naatriumvesinikkarbonaat+kaaliumkloriid - suukaudse lahuse pulber - 105g+2,8g+1,43g+0,37g 4tk

Estonia - Tiếng Estonia - Ravimiamet

fresenius kabi deutschland gmbh - hüdroksüetüültärklis+naatriumkloriid - infusioonilahus - 60mg+9mg 1ml 250ml 40tk; 60mg+9mg 1ml 250ml 30tk; 60mg+9mg 1ml 500ml 15tk; 60mg+9mg 1ml 500ml 1tk; 60mg+9mg 1ml 250ml 20tk; 60mg+9mg 1ml 500ml 10tk; 60mg+9mg 1ml 250ml 1tk; 60mg+9mg 1ml 250ml 10tk; 60mg+9mg 1ml 250ml 25tk

Liên Minh Châu Âu - Tiếng Estonia - EMA (European Medicines Agency)

pfizer limited - celecoxib - adenomatoos polyposis coli - antineoplastilised ained - onsenal on näidustatud adenomatoossete soolepolüüpide perekondliku adenomatoosse polüpoosi (fap) arvu vähendamise dieedile operatsiooni ja edasise endoskoopiline järelevalve (vt lõik 4. mõju onsenal-indutseeritud vähendamine polyp koormust oht soolestiku vähi ei ole tõestatud (vt lõigud 4. 4 ja 5.

Estonia - Tiếng Estonia - Ravimiamet

teva pharma b.v. - doksorubitsiin - infusioonilahuse kontsentraat - 2mg 1ml 100ml 1tk; 2mg 1ml 5ml 1tk; 2mg 1ml 10ml 1tk

Estonia - Tiếng Estonia - Ravimiamet

gedeon richter plc. - paroksetiin - õhukese polümeerikattega tablett - 20mg 30tk

Estonia - Tiếng Estonia - Ravimiamet

b. braun melsungen ag - ropivakaiin - süstelahus - 7,5mg 1ml 20ml 20tk; 7,5mg 1ml 10ml 20tk